Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
NKTR-255
Sort By
Newest First
Sign in
1 / 1
1 / 1
NKTR-255
Nektar Presents Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia
Nektar Therapeutics
PR-10-24-NI-85
Nov 08, 2024
